Abingworth LLP

Insider profile

Performance

Overall performance
1.8

Performance over holding periods
1.8
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 17% 68% 82%
Transactions
8 12% Buy
34 71% Buy
47 69% Buy
Abingworth LLP's trades of Sierra Oncology Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-02-01 2022-01-31 B Purchase
44,001 -40.9%
73.57
US$2,317,158
44,001 -40.9% 73.57 US$2,317,158
2021-05-18 2021-05-18 B Purchase
62,015 -1.0%
37.99
US$395,038
62,015 -1.0% 37.99 US$395,038
2020-10-21 2020-10-20 S Sale
41,432 +33.9%
317.36
US$471,087
41,432 +33.9% 317.36 US$471,087
2020-10-20 2020-10-19 S Sale
196,423 -4.8%
27.86
US$5,472,345
196,423 -4.8% 27.86 US$5,472,345
2020-10-20 2020-10-16 S Sale
94,218 -2.3%
26.68
US$2,513,736
94,218 -2.3% 26.68 US$2,513,736
2020-10-16 2020-10-15 S Sale
3,700 -0.1%
26.32
US$97,384
3,700 -0.1% 26.32 US$97,384
2020-10-16 2020-10-14 S Sale
81,925 -1.9%
27.08
US$2,218,529
81,925 -1.9% 27.08 US$2,218,529
2020-10-14 2020-10-13 S Sale
86,819 -2.0%
28.43
US$2,468,264
86,819 -2.0% 28.43 US$2,468,264
2020-10-14 2020-10-12 S Sale
115,541 -2.6%
29.09
US$3,361,088
115,541 -2.6% 29.09 US$3,361,088
2020-08-20 2020-08-18 S Sale
986,842 -18.1%
19.00
US$18,749,998
986,842 -18.1% 19.00 US$18,749,998
2020-07-06 2020-06-26 B Purchase
3,333,330 +47.8%
1.65
US$5,499,994
3,333,330 +47.8% 1.65 US$5,499,994
2019-10-29 2019-10-25 B Purchase
2,300,000 +49.3%
1.20
US$2,760,000
2,300,000 +49.3% 1.20 US$2,760,000